HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Despite treatment advances, ‘much to improve upon’ in high-risk neuroblastoma Jennifer R. Southall
-
- Is tandem transplant appropriate for patients with high-risk neuroblastoma?
- Bringing drug costs down a ‘peg’ or two John Sweetenham, MD, FRCP, FACP
- Four actionable targets for metastatic colorectal cancer that APPs should know
- Azacitidine plus venetoclax effective, safe for certain patients with AML John DeRosier
- Lipophilic statin use associated with reduced ovarian cancer mortality John DeRosier
- Germline mutations common among young adults with early-onset cancers Jennifer R. Southall
- Adjuvant osimertinib extends DFS in EGFR-mutated NSCLC Mark Leiser
- Adjuvant atezolizumab fails to extend DFS in high-risk urothelial carcinoma Mark Leiser
-
- First-line doxorubicin plus trabectedin effective, safe for metastatic leiomyosarcoma John DeRosier
- Weekly cisplatin a potential new standard for HNSCC John DeRosier
- Donafenib extends OS in advanced liver cancer John DeRosier
- Tucatinib combination extends OS in HER2-positive breast cancer with brain metastases Jennifer R. Southall
- Pembrolizumab extends PFS in relapsed or refractory classical Hodgkin lymphoma Mark Leiser
- Rituximab regimen extends EFS, OS in pediatric non-Hodgkin lymphoma subset John DeRosier
- Interleukin-1 beta inhibition improves hemoglobin levels, reduces anemia incidence John DeRosier
- Sharp declines in melanoma mortality 'unprecedented in cancer medicine' John DeRosier
-
- Lurbinectedin approved for metastatic small cell lung cancer
- FDA grants orphan drug status to DKN-01 for certain gastrointestinal cancers
- FDA grants fast track status to fruquintinib for metastatic colorectal cancer
- FDA expands Mylotarg approval for pediatric AML subset
- FDA expands Gardasil 9 approval for head and neck cancer prevention
- FDA approves Tazverik for follicular lymphoma subset
- FDA approves Nyvepria, biosimilar to pegfilgrastim, to reduce infections
- FDA grants fast track designation to Onivyde for advanced pancreatic cancer
-
- FDA approves Keytruda for tumor mutational burden-high solid tumors
- Cancer prevention guideline emphasizes more physical activity, less meat and alcohol Jennifer R. Southall
- AACR Academy names president-elect Alexandra (Sasha) Todak
- Children’s Hospital of Philadelphia named best hospital for pediatric cancer